1. Apoptosis Autophagy NF-κB MAPK/ERK Pathway PI3K/Akt/mTOR Stem Cell/Wnt JAK/STAT Signaling Protein Tyrosine Kinase/RTK Epigenetics
  2. Apoptosis Autophagy NF-κB p38 MAPK PI3K Akt mTOR STAT JAK
  3. Physalin A

Physalin A is a biologically active withanolide. Physalin A shows anti-inflammatory, antifibrotic and ameliorative effects on autophagy in models of disc degeneration. Physalin A has antitumor activity and can induce apoptosis, ROS production and G2/M phase cell cycle arrest. Besides. Physalin A can significantly increase the activity of quinone reductase and increase the expression of detoxifying enzymesc.

For research use only. We do not sell to patients.

Physalin A Chemical Structure

Physalin A Chemical Structure

CAS No. : 23027-91-0

Size Price Stock Quantity
1 mg USD 360 In-stock
5 mg USD 920 In-stock
10 mg USD 1480 In-stock
50 mg   Get quote  
100 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Top Publications Citing Use of Products

View All NF-κB Isoform Specific Products:

View All p38 MAPK Isoform Specific Products:

View All PI3K Isoform Specific Products:

View All Akt Isoform Specific Products:

View All mTOR Isoform Specific Products:

View All STAT Isoform Specific Products:

View All JAK Isoform Specific Products:

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Physalin A is a biologically active withanolide. Physalin A shows anti-inflammatory, antifibrotic and ameliorative effects on autophagy in models of disc degeneration. Physalin A has antitumor activity and can induce apoptosis, ROS production and G2/M phase cell cycle arrest. Besides. Physalin A can significantly increase the activity of quinone reductase and increase the expression of detoxifying enzymesc[1][2][3][4].

Cellular Effect
Cell Line Type Value Description References
HeLa IC50
> 50 μM
Compound: PA-2
Inhibition of TNFalpha-induced IkappaBalpha (unknown origin) phosphorylation expressed in human HeLa cells pretreated 30 mins before TNFalpha addition measured up to 120 mins by ELISA in presence of proteasome inhibitor MG-132
Inhibition of TNFalpha-induced IkappaBalpha (unknown origin) phosphorylation expressed in human HeLa cells pretreated 30 mins before TNFalpha addition measured up to 120 mins by ELISA in presence of proteasome inhibitor MG-132
[PMID: 24900739]
HeLa IC50
22.7 μM
Compound: PA-2
Inhibition of TNFalpha-induced NF-kappaB activation (unknown origin) expressed in human HeLa cells pretreated 30 mins before TNFalpha addition after 7 hrs by luciferase reporter gene assay
Inhibition of TNFalpha-induced NF-kappaB activation (unknown origin) expressed in human HeLa cells pretreated 30 mins before TNFalpha addition after 7 hrs by luciferase reporter gene assay
[PMID: 24900739]
HT-1080 IC50
10.7 μM
Compound: 1
Cytotoxicity against human HT1080 cells assessed as growth inhibition after 24 hrs by MTT assay
Cytotoxicity against human HT1080 cells assessed as growth inhibition after 24 hrs by MTT assay
[PMID: 23647462]
In Vitro

Physalin A (28.4 μM; 0-24 h) induces ROS production, G2/M phase cell cycle arrest and triggeres phosphorylation of P38 and ERK in A549 cells[2].
Physalin A (0-15 μM; 24 h) inhibits the cell viability and induces cell apoptosis in human non-small cell lung cancer[3].
Physalin A (20 μM; 48 h) improves TGF-β1-induced fibrosis in NP cells[4].
Physalin A (20 μM; 48 h) reduces inflammation by inhibiting NF-κB and MAPK signaling pathways and enhances autophagy by blocking PI3K/AKT/mTOR signaling pathways in IL-1β-treated NP cells[4].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[2]

Cell Line: A549 cells
Concentration: 28.4 μM
Incubation Time: 6, 12 and 24 h
Result: Increased the phosphorylation levels P38 and ERK in a time-dependent manner.

Western Blot Analysis[3]

Cell Line: H292, H358 and H1975 cells
Concentration: 0, 2.5, 5, 10 and 15 μM
Incubation Time: 24 h
Result: Increased the levels of apoptotic markers, such as cleaved poly(ADP-ribose) polymerase (PARP), cleaved caspase-3 and cleaved caspase-9.

Western Blot Analysis[4]

Cell Line: NP cells were harvested from the inner tissue of tail disc of SpragueDawley rats
Concentration: 20 μM
Incubation Time: 48 h
Result: Reduced the phosphorylation levels of IKKα/β, IκBα and P65.
Reduced the phosphorylation levels of JNK, ERK and P38.
Reduced the phosphorylation levels of PI3K. AKT and mTOR.
In Vivo

Physalin A (40-80 mg/kg; Intraperitoneal injection; 10 days) has antitumor effect in H292 xenograft tumor model[3].
Physalin A (2 μL 20 μM; Injection of nucleus pulposus of the disc; Single dose) has a protective effect in a rat model of disc degeneration[4].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male BALB/c mice[3]
Dosage: 40 and 80 mg/kg
Administration: Intraperitoneal injection (i.p.); 10 days
Result: Significantly reduced the mean tumor volume and tumor weight, had the least effect on the weight of mice.
Decreased Tyr705-p-STAT3 levels, and increased caspase-3 activation.
Animal Model: Male Sprague-Dawley rats aged 6-8 weeks old (220±20 g) with intervertebral disc degeneration[4]
Dosage: 2 μL 20 μM
Administration: Injection of nucleus pulposus of the disc; Single dose
Result: Alleviated disc degradation.
Reduced inflammation and fibrosis.
Molecular Weight

526.53

Formula

C28H30O10

CAS No.
Appearance

Solid

Color

White to off-white

SMILES

C[C@@]([C@@](OC1=O)([H])C2)(OC3=O)[C@@]([C@@]3(CC[C@@]([C@]45C)([H])[C@@]6([H])[C@@H](C=C4CC=CC5=O)O)O)(O[C@@]76O)[C@](C7=O)([H])[C@]2(C1=C)C

Structure Classification
Initial Source
Shipping

Room temperature in continental US; may vary elsewhere.

Storage

4°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Salutation

Applicant Name *

 

Email Address *

Phone Number *

 

Organization Name *

Department *

 

Requested quantity *

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Physalin A
Cat. No.:
HY-N9942
Quantity:
MCE Japan Authorized Agent: